Molecular Mechanisms of COPD Exacerbations. Effect of Low-Dose Theophylline
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 35
- 试验地点
- 1
- 主要终点
- HDAC activity in alveolar macrophages
研究概览
简要总结
Molecular mechanisms of COPD exacerbations and the modulating effect of low dose theophylline on that inflammation are elucidated in this project. NF-kappa B-dependent pathway and acetylation status of nuclear histones are to be studied.Design: controlled, prospective and randomized study with or without theophylline, a potent HDAC activator.Objectives: 1) To determine NF-kB activation, histone deacetylase (HDAC) and histone acetyl-transferase (HAT) activity in sputum macrophages and blood monocytes during an episode of exacerbation and 3 months later, once stability is achieved. To correlate these measurements with inflammatory and oxidative stress markers and with pulmonary function and clinical variables. 2) To assess the effect of theophylline on previous molecular, functional and clinical data. Method: 25 patients with COPD will be recruited during an episode of exacerbation requiring hospitalization. NF-kB activation, HDAC and HAT activity, markers of inflammation and oxidative stress will be determined with specific assays. These determinations will be repeated once the patient is stable and compared with smokers and non smoker controls with normal lung function
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 40 Years 至 75 Years(Adult, Older Adult)
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- •Severe COPD according to GOLD guidelines
- •Age between 40 and 75
- •Admission to hospital due to COPD exacerbation
排除标准
- •History of asthma
- •Pulmonary embolism
- •Pneumonia
- •Other chronic inflammatory disease
- •Patient on theophylline at the time of admission
- •Patient on oral steroids at the time of admission
研究组 & 干预措施
1
Low-dose theophylline on top of standard therapy for COPD exacerbation
干预措施: Theophylline (Drug)
结局指标
主要结局
HDAC activity in alveolar macrophages
时间窗: 3 months
次要结局
- Lung function(3 months)
- Inflammatory cytokine release in sputum and serum(3 months)
